Completed

Clinical Evaluation of the Improvement in Bioavailability of Four Magnesium-based Products in 40 Human Volunteers After an Oral Intake by Assessing Magnesium Absorption Kinetics in Plasma for 8 Hours

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Dietary supplementation with Microencapsulated Magnesium

+ Dietary supplementation with Magnesium Oxide

+ Dietary supplementation with Magnesium Citrate

Dietary Supplement
Who is being recruted

From 20 to 55 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Interventional
Study Start: January 2024
See protocol details

Summary

Principal SponsorBionos Biotech S.L.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 28, 2024

Actual date on which the first participant was enrolled.

This study aims to understand how well the body absorbs different forms of magnesium when taken as supplements. Magnesium is a vital nutrient needed for many body functions, including the creation of DNA and energy production. Many people do not get enough magnesium in their diet, so this research could help determine which magnesium supplements are most effective in improving magnesium levels in the body. The study involves 40 healthy volunteers aged between 20 and 55 years who will help researchers compare four types of magnesium supplements: Microencapsulated Magnesium, Magnesium Oxide, Magnesium Citrate, and Magnesium Bisglycinate. Participants will follow a special low-magnesium diet for a week before starting the test. On the test day, after fasting for 8 hours, a small blood sample will be taken from their finger, and they will then take one of the magnesium supplements orally. Blood samples will be collected at several intervals over the next 8 hours to measure the magnesium in their blood. Each participant will repeat this process for each of the four magnesium products over four weeks. The study ensures that meals and water intake are controlled to maintain consistent conditions. Blood testing is done in a non-invasive manner, and the results will help determine which supplement is most readily absorbed by the body.

Official TitleClinical Evaluation of the Improvement in Bioavailability of Four Magnesium-based Products in 40 Human Volunteers After an Oral Intake by Assessing Magnesium Absorption Kinetics in Plasma for 8 Hours
NCT06225349
Principal SponsorBionos Biotech S.L.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

40 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 20 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

5 inclusion criteria required to participate
Healthy volunteers between 20 and 55 years of all races/ethnicities.

Body mass index of 18-35 kg/m2.

Last participation in a clinical study of this type must be at least 15 days before the start of this study.

Fasting conditions during 8 hours before the experiment (with the exception of low mineralization water).

Show More Criteria

9 exclusion criteria prevent from participating
People with gastrointestinal diseases (diabetes, gastritis, Crohn's disease, celiac disease, ulcers, intolerances, etc.).

People with cardiorespiratory diseases (chronic bronchitis, chronic obstructive pulmonary disease, pulmonary emphysema, asthma and bronchiectasis, thrombi, heart disease, heart disorders, arrhythmias, insufficiencies, etc.).

Pregnant or lactating women or who plan to become pregnant during the study.

People under medical treatment in the weeks prior to the study that could interfere with the evaluations of the present study (according to the investigator's criteria).

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

4 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
This group will be provided with a the product Microencapsulated Magnesium.

Group II

Experimental
This group will be provided with a the product Magnesium Oxide.

Group III

Experimental
This group will be provided with a the product Magnesium Citrate.

Group IV

Experimental
This group will be provided with a the product Magnesium Bisglycinate.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Bionos Biotech S.L.

Valencia, SpainOpen Bionos Biotech S.L. in Google Maps
CompletedOne Study Center